License to Cure for Medical Device
Accelerate the delivery of innovative, safe and fully compliant medical devices
Drive your global regulatory strategy while ensuring unmatched quality, safety and efficacy
Data Integrity: The foundation of good science (Axendia)
Improved medical device design, testing, clinical diagnosis and regulatory science along with ”in-silico” design, a shift toward biologics, and outcomes-based health economics can help accelerate the best products to market, reducing the overall Life Sciences industry attrition rate.
The goal is to create an integrated framework for compliant innovation, embed quality and regulatory best practices early in the development process, and to provide end-to-end product traceability throughout the lifecycle of the product. This process allows for higher quality, compliant products and faster regulatory approvals.
Ensure full regulatory compliance to:
An integrated framework for compliant innovation, with embedded quality and regulatory best practices will help meet the demands of both government regulators and patient demands.
The 3DEXPERIENCE® platform is the only solution providing a single environment where manufacturers can work more closely with customers and develop customized solutions at unprecedented speed, efficiency, and cost. Enhanced multi-site collaboration allows them to manage and coordinate facility capacity, operations, inventory and resources in a way that’s profitable and efficient.
Discover Dassault Systèmes®' Life Sciences industry solutions aiming to improve patient and physician experience, and organizational business excellence.
The 3DEXPERIENCE platform’s integrated business framework helps Osstem Implant eliminate traditionally disconnected processes and data, and increase the efficiency and accuracy of its product quality control.
"Gaining global market share calls for diversification and rapid delivery of innovative products to the consumer. Rising scrutiny around health related products forces us to devote much of our R&D to regulatory activities rather than on developing new products."